[۱] سپیده خوئی، رضا بافکاری، یوسف باقری، "نانوحاملهای بسپاری: ساخت، خصوصیات و کاربرد در دارورسانی،" انتشارات دانشگاه تهران، 3517، 1396.
[2] R. Singh, J.W. Lillard Jr, “Nanoparticle-based targeted drug delivery,” Experimental and molecular pathology, 86(3), 215-223, 2009.
[3] KE. Drexler, “Engines of Creation: The Coming Era of Nanotechnology,” New York, NY: Anchor Press/Doubleday, 1986.
[4] N.A. Ochekpe, P.O. Olorunfemi, N.C. Ngwuluka, “Nanotechnology and drug delivery part 1: background and applications,” Tropical journal of pharmaceutical research, 8(3), 2009.
[5] H. Maeda, “The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting,” Advances in enzyme regulation, 2001.
[6] W. Zhang, Z. Zhang, Y. Zhang, “The application of carbon nanotubes in target drug delivery systems for cancer therapies,” Nanoscale research letters, 6(1), 555, 2011.
[7] M. Karimi, N. Solati, M. Amiri, H. Mirshekari, E. Mohamed, M. Taheri, A. Ghasemi, “Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle,” Expert opinion on drug delivery, 12(7), 1071-1087, 2015.
[8] A. Kunzmann, B. Andersson, T. Thurnherr, H. Krug, A. Scheynius, B. Fadeel, “Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation,” Biochimica et Biophysica Acta (BBA)-General Subjects, 1810(3), 361-373, 2011.
[9] S.Z. Mousavi, S. Amjad-Iranagh, Y. Nademi, H. Modarress, “Carbon nanotube-encapsulated drug penetration through the cell membrane: an investigation based on steered molecular dynamics simulation,” The Journal of membrane biology, 246(9), 697-704, 2013.
[10] A. Mejri, D. Vardanega, B. Tangour, T. Gharbi, F. Picaud, “Encapsulation into carbon nanotubes and release of anticancer cisplatin drug molecule,” The Journal of Physical Chemistry B, 119(2), 604-611, 2015.
[11] N. Razavilar, “Design of Macromolecular Anti-cancer Drug Delivery Systems using Molecular Dynamics Simulation,” 2015.
[12] J. Phillips, T. Isgro, M. Sotomayor, E. Villa, “NAMD TUTORIAL,” 2003.
[13] I.R. Sasselli, R.V. Ulijn, T. Tuttle, “CHARMM force field parameterization protocol for self-assembling peptide amphiphiles: the Fmoc moiety,” Physical Chemistry Chemical Physics, 18(6), 4659-4667, 2016.
[14] H.C. Andersen, “Molecular dynamics simulations at constant pressure and/or temperature,” Journal of Chemical Physics, (72), 2384-2393, 1980.
[15] سیف الله جلیلی، "شبیهسازیهای رایانهای (دینامیک مولکولی و مونت کارلو)،" ویرایش دوم، نشر دانشگاه خواجه نصیرالدین طوسی، تهران، ۱۳۹۰.
[16] M.D. Hanwell, D.E. Curtis, D.C. Lonie, T. Vandermeersch, E. Zurek, G.R. Hutchison, “Avogadro: an advanced semantic chemical editor, visualization, and analysis platform,” Journal of cheminformatics, 4(1), 1-17, 2012.
[17] Y. Alexeev, M. P Mazanetz, O. Ichihara, D. G Fedorov, “GAMESS as a free quantum-mechanical platform for drug research,” Current topics in medicinal chemistry, 12(18), 2013-2033, 2012.
[18] W. Humphrey, A. Dalke, K. Schulten, “VMD: visual molecular dynamics,” Journal of molecular graphics, 14(1), 33-38, 1996.
[19] G.J. Hardy, R. Nayak, S.M. Alam, J.G. Shapter, F. Heinrich, S. Zauscher, “Biomimetic supported lipid bilayers with high cholesterol content formed by α-helical peptide-induced vesicle fusion,” Journal of materials chemistry, 22(37), 19506-19513, 2012.
[20] A. C. Alves, D. Ribeiro, C. Nunes, S. Reis, “Biophysics in cancer: The relevance of drug-membrane interaction studies,” Biochimica et Biophysica Acta (BBA)-Biomembranes, 1858(9), 2231-2244, 2016.
[21] J.C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, K. Schulten, “Scalable molecular dynamics with NAMD,” Journal of computational chemistry, 26(16), 1781-1802, 2005.